李佳（邮箱：lijia0803@126.com），博士，副教授，硕士研究生导师。2018年毕业于中国药科大学，获博士学位。2021年获得校C类特聘引进人才待遇，任学院学院生理学系专任教师。

研究方向聚焦于心血管疾病代谢紊乱分子机制与中药干预作用。主持国家自然科学基金青年基金项目(2021)，江苏省自然科学基金青年基金项目(2019)，中国博士后科学基金面上项目(2018)。以第一作者或通讯作者身份在Redox Biology (2022), Theranostics (2021), British Journal of Pharmacology (2019)等国际期刊发表SCI论文数篇。

近年五篇代表性研究论文：

1.Ni XC#, Wang HF#, Cai YY, Yang D, Alolga RN, Liu B, Li J*, Huang FQ*. Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke. Redox Biol. 2022; 54:102363.

2.Jiang L#, Yin X#, Chen YH, Chen Y, Jiang W, Zheng H, Huang FQ, Liu B, Zhou W, Qi LW*, Li J*. Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics. 2021; 11:1703-1720.

3.Li J#, Chen YH#, Li LZ#, Wang F#, Song W, Alolga RN, Zhou W, Yu H*, Huang FQ*, Yin X*. Omics and Transgenic Analyses Reveal that Salvianolic Acid B Exhibits its Anti-Inflammatory Effects through Inhibiting the Mincle-Syk-Related Pathway in Macrophages. J Proteome Res. 2021; 20:3734-3748.

4.Lou MD#, Li J#, Cheng Y, Xiao N, Ma G, Li P, Liu B, Liu Q*, Qi LW*. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1. Br J Pharmacol. 2019; 176:2962-2976.

5.Lu YT, Li LZ, Yang YL, Yin X, Liu Q, Zhang L, Liu K, Liu B, Li J*, Qi LW*. Succinate induces aberrant mitochondrial fission in cardiomyocytes through GPR91 signaling. Cell Death Dis. 2018; 9:672.